UnitedHealth Group Incorporated (NYSE:UNH) Director Richard T. Burke Sells 2,500 Shares

UnitedHealth Group Incorporated (NYSE:UNH) Director Richard T. Burke sold 2,500 shares of the stock in a transaction dated Tuesday, November 23rd. The shares were sold at an average price of $444.70, for a total value of $1,111,750.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.

UNH opened at $450.16 on Thursday. UnitedHealth Group Incorporated has a 12 month low of $320.35 and a 12 month high of $466.00. The stock has a market capitalization of $423.98 billion, a price-to-earnings ratio of 27.93, a PEG ratio of 1.75 and a beta of 0.85. The company has a debt-to-equity ratio of 0.59, a current ratio of 0.77 and a quick ratio of 0.77. The business has a fifty day moving average price of $430.47 and a 200 day moving average price of $418.01.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Thursday, October 14th. The healthcare conglomerate reported $4.52 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $4.41 by $0.11. The business had revenue of $72.34 billion during the quarter, compared to analysts’ expectations of $71.24 billion. UnitedHealth Group had a return on equity of 23.08% and a net margin of 5.52%. The business’s quarterly revenue was up 11.1% compared to the same quarter last year. During the same period in the prior year, the firm posted $3.51 EPS. On average, research analysts anticipate that UnitedHealth Group Incorporated will post 18.84 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 14th. Stockholders of record on Monday, December 6th will be given a dividend of $1.45 per share. The ex-dividend date of this dividend is Friday, December 3rd. This represents a $5.80 annualized dividend and a dividend yield of 1.29%. UnitedHealth Group’s dividend payout ratio is currently 35.98%.

UNH has been the subject of several research analyst reports. BMO Capital Markets raised their price objective on UnitedHealth Group from $435.00 to $475.00 and gave the stock a “market perform” rating in a research note on Monday, October 18th. Credit Suisse Group raised their price objective on UnitedHealth Group from $462.00 to $495.00 and gave the company an “outperform” rating in a report on Friday, October 15th. Mizuho raised their price objective on UnitedHealth Group from $455.00 to $500.00 and gave the company a “buy” rating in a report on Wednesday, November 10th. Oppenheimer lifted their price target on UnitedHealth Group from $465.00 to $475.00 and gave the stock an “outperform” rating in a research note on Friday, October 15th. Finally, Cowen initiated coverage on UnitedHealth Group in a research note on Thursday, September 9th. They issued an “outperform” rating and a $478.00 price target on the stock. One research analyst has rated the stock with a hold rating, twenty-one have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Buy” and an average target price of $477.35.

Large investors have recently added to or reduced their stakes in the company. BlackRock Inc. boosted its position in shares of UnitedHealth Group by 1.0% in the 3rd quarter. BlackRock Inc. now owns 69,706,545 shares of the healthcare conglomerate’s stock valued at $27,237,133,000 after purchasing an additional 679,255 shares during the period. FMR LLC boosted its position in shares of UnitedHealth Group by 0.6% in the 2nd quarter. FMR LLC now owns 50,452,463 shares of the healthcare conglomerate’s stock valued at $20,203,185,000 after purchasing an additional 291,660 shares during the period. State Street Corp boosted its position in shares of UnitedHealth Group by 1.9% in the 2nd quarter. State Street Corp now owns 44,530,535 shares of the healthcare conglomerate’s stock valued at $17,831,807,000 after purchasing an additional 838,941 shares during the period. Capital World Investors boosted its position in shares of UnitedHealth Group by 0.4% in the 3rd quarter. Capital World Investors now owns 34,268,409 shares of the healthcare conglomerate’s stock valued at $13,390,353,000 after purchasing an additional 149,756 shares during the period. Finally, EP Wealth Advisors LLC boosted its position in shares of UnitedHealth Group by 49,050.0% in the 3rd quarter. EP Wealth Advisors LLC now owns 15,517,624 shares of the healthcare conglomerate’s stock valued at $11,590,000 after purchasing an additional 15,486,052 shares during the period. 86.20% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Company Profile

UnitedHealth Group, Inc engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum’s capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience.

Further Reading: The Discount Rate – What You Need to Know

Insider Buying and Selling by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.